Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, has received FDA 510(k) clearance for the VersaLift Expandable Interbody System, a solution for TLIF and PLIF procedures featuring a low 6mm starting height.
Designed to support minimally invasive surgical access, VersaLift offers one of the smallest starting heights available for a TLIF expandable interbody implant, beginning at just 6mm. Approved for 8, 10, and 12mm widths with up to 15° of lordotic correction, the system’s low-profile design is intended to facilitate insertion through constrained anatomy while minimizing tissue disruption and nerve retraction.
VersaLift features controlled in-situ expansion designed to maintain implant length throughout deployment while supporting restoration of anatomic disc height and indirect decompression of neural elements. Streamlined instrumentation is designed to help surgeons efficiently achieve alignment and procedural goals while maintaining a simplified workflow.
“VersaLift represents our continued focus on procedural innovation and minimally invasive spine surgery,” said Rich Mueller, President & CEO. “By combining a 6mm starting height with controlled in-situ expansion, VersaLift provides surgeons with a versatile expandable technology designed to address challenging anatomy while supporting procedural efficiency.”
